{"id":"https://openalex.org/W2471247568","doi":"https://doi.org/10.1158/2159-8290.cd-16-0297","title":"MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF -Mutated Colorectal Cancer","display_name":"MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF -Mutated Colorectal Cancer","alternate_titles":[],"publication_year":2016,"publication_date":"2016-06-20","ids":{"openalex":"https://openalex.org/W2471247568","doi":"https://doi.org/10.1158/2159-8290.cd-16-0297","mag":"2471247568","pmid":"https://pubmed.ncbi.nlm.nih.gov/27325282"},"language":"en","primary_location":{"id":"doi:10.1158/2159-8290.cd-16-0297","doi":"https://doi.org/10.1158/2159-8290.cd-16-0297","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2159-8290.cd-16-0297","pdf_url":null,"source":{"id":"https://openalex.org/S2486275289","display_name":"Cancer Discovery","issn_l":"2159-8274","issn":["2159-8274","2159-8290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Discovery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2471247568"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://iris.unito.it/bitstream/2318/1591711/1/Pietrantonio_CD-16-0297_PostPrint_4aperto.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079437223","display_name":"Filippo Pietrantonio","orcid":"https://orcid.org/0000-0002-8530-8420","observed_orcids":["https://orcid.org/0000-0002-8530-8420"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Filippo Pietrantonio","raw_affiliation_strings":["1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067091212","display_name":"Daniele Oddo","orcid":"https://orcid.org/0000-0001-6179-1668","observed_orcids":["https://orcid.org/0000-0001-6179-1668"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniele Oddo","raw_affiliation_strings":["2Department of Oncology, University of Torino, Candiolo (TO), Italy","3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","2Department of Oncology, University of Torino, Candiolo (TO), Italy.; 3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Oncology, University of Torino, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I4210151091"]},{"raw_affiliation_string":"2Department of Oncology, University of Torino, Candiolo (TO), Italy.; 3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038699632","display_name":"Annunziata Gloghini","orcid":"https://orcid.org/0000-0002-7226-1942","observed_orcids":["https://orcid.org/0000-0002-7226-1942"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Annunziata Gloghini","raw_affiliation_strings":["4Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006266882","display_name":"Emanuele Valtorta","orcid":"https://orcid.org/0000-0002-5087-6233","observed_orcids":["https://orcid.org/0000-0002-5087-6233"]},"institutions":[{"id":"https://openalex.org/I4210094195","display_name":"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda","ror":"https://ror.org/00htrxv69","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094195"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emanuele Valtorta","raw_affiliation_strings":["5Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy","institution_ids":["https://openalex.org/I4210094195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019125073","display_name":"Rosa Berenato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rosa Berenato","raw_affiliation_strings":["1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032586288","display_name":"Ludovic Barault","orcid":"https://orcid.org/0000-0001-5227-5047","observed_orcids":["https://orcid.org/0000-0001-5227-5047"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ludovic Barault","raw_affiliation_strings":["3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103737138","display_name":"Marta Caporale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marta Caporale","raw_affiliation_strings":["1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012265647","display_name":"Adele Busico","orcid":"https://orcid.org/0000-0002-5808-0387","observed_orcids":["https://orcid.org/0000-0002-5808-0387"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Adele Busico","raw_affiliation_strings":["4Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064495942","display_name":"Federica Morano","orcid":"https://orcid.org/0000-0002-5306-3596","observed_orcids":["https://orcid.org/0000-0002-5306-3596"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federica Morano","raw_affiliation_strings":["1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036824813","display_name":"Ambra V. Gualeni","orcid":"https://orcid.org/0000-0002-8718-1005","observed_orcids":["https://orcid.org/0000-0002-8718-1005"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ambra Vittoria Gualeni","raw_affiliation_strings":["4Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052176654","display_name":"Alessandra Alessi","orcid":"https://orcid.org/0000-0003-3853-1926","observed_orcids":["https://orcid.org/0000-0003-3853-1926"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessandra Alessi","raw_affiliation_strings":["6Nuclear Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Nuclear Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031332948","display_name":"Giulia Siravegna","orcid":"https://orcid.org/0000-0002-7132-6484","observed_orcids":["https://orcid.org/0000-0002-7132-6484"]},"institutions":[{"id":"https://openalex.org/I4210114103","display_name":"IFOM","ror":"https://ror.org/02hcsa680","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210114103"]},{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Siravegna","raw_affiliation_strings":["2Department of Oncology, University of Torino, Candiolo (TO), Italy","3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","7FIRC Institute of Molecular Oncology (IFOM), Milan, Italy","2Department of Oncology, University of Torino, Candiolo (TO), Italy.; 3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy.; 7FIRC Institute of Molecular Oncology (IFOM), Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Oncology, University of Torino, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I4210151091"]},{"raw_affiliation_string":"7FIRC Institute of Molecular Oncology (IFOM), Milan, Italy","institution_ids":["https://openalex.org/I4210114103"]},{"raw_affiliation_string":"2Department of Oncology, University of Torino, Candiolo (TO), Italy.; 3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy.; 7FIRC Institute of Molecular Oncology (IFOM), Milan, Italy","institution_ids":["https://openalex.org/I4210114103","https://openalex.org/I4210151091","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015740152","display_name":"Federica Perrone","orcid":"https://orcid.org/0000-0003-4406-8245","observed_orcids":["https://orcid.org/0000-0003-4406-8245","https://orcid.org/0009-0008-4469-3386"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federica Perrone","raw_affiliation_strings":["4Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075464309","display_name":"Maria Di Bartolomeo","orcid":"https://orcid.org/0000-0002-7954-6609","observed_orcids":["https://orcid.org/0000-0002-7954-6609"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Di Bartolomeo","raw_affiliation_strings":["1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064011158","display_name":"Alberto Bardelli","orcid":"https://orcid.org/0000-0003-1647-5070","observed_orcids":["https://orcid.org/0000-0003-1647-5070"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alberto Bardelli","raw_affiliation_strings":["2Department of Oncology, University of Torino, Candiolo (TO), Italy","3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","2Department of Oncology, University of Torino, Candiolo (TO), Italy.; 3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Oncology, University of Torino, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I4210151091"]},{"raw_affiliation_string":"2Department of Oncology, University of Torino, Candiolo (TO), Italy.; 3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I4210151091"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009935310","display_name":"Filippo de Braud","orcid":"https://orcid.org/0000-0003-0103-730X","observed_orcids":["https://orcid.org/0000-0003-0103-730X"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Filippo de Braud","raw_affiliation_strings":["1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","8Department of Oncology, Universit\u00e0 degli Studi di Milano, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]},{"raw_affiliation_string":"8Department of Oncology, Universit\u00e0 degli Studi di Milano, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004556147","display_name":"Federica Di Nicolantonio","orcid":"https://orcid.org/0000-0001-9618-2010","observed_orcids":["https://orcid.org/0000-0001-9618-2010"]},"institutions":[{"id":"https://openalex.org/I4210151091","display_name":"Candiolo Cancer Institute","ror":"https://ror.org/04wadq306","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210151091","https://openalex.org/I4210153126","https://openalex.org/I4210167100"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federica Di Nicolantonio","raw_affiliation_strings":["2Department of Oncology, University of Torino, Candiolo (TO), Italy","3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","2Department of Oncology, University of Torino, Candiolo (TO), Italy.; 3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Oncology, University of Torino, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I55143463"]},{"raw_affiliation_string":"3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I4210151091"]},{"raw_affiliation_string":"2Department of Oncology, University of Torino, Candiolo (TO), Italy.; 3Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy","institution_ids":["https://openalex.org/I4210151091"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.7705,"has_fulltext":true,"cited_by_count":112,"citation_normalized_percentile":{"value":0.98728296,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"6","issue":"9","first_page":"963","last_page":"971"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/met-amplification","display_name":"MET amplification","score":0.8349999785423279},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8569999933242798},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.8429999947547913},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9860000014305115},{"id":"https://openalex.org/keywords/panitumumab","display_name":"panitumumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.9350000023841858},{"id":"https://openalex.org/keywords/clonal-expansion","display_name":"clonal expansion","score":0.9070000052452087}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.8291884660720825},{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.7902716994285583},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7206801176071167},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6869767904281616},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6411689519882202},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.5942084193229675},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5709093809127808},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5524885654449463},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.482384592294693},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.43181395530700684},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.42960017919540405},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.42715612053871155},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4175894260406494},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38359981775283813},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.31676873564720154},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.2796834111213684},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.2025861144065857},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.13926184177398682},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09279227256774902},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000072078","descriptor_name":"Positron Emission Tomography Computed Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077484","descriptor_name":"Vemurafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005784","descriptor_name":"Gene Amplification","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014057","descriptor_name":"Tomography, X-Ray Computed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019859","descriptor_name":"Proto-Oncogene Proteins c-met","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019859","descriptor_name":"Proto-Oncogene Proteins c-met","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D057915","descriptor_name":"Drug Substitution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/2159-8290.cd-16-0297","doi":"https://doi.org/10.1158/2159-8290.cd-16-0297","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2159-8290.cd-16-0297","pdf_url":null,"source":{"id":"https://openalex.org/S2486275289","display_name":"Cancer Discovery","issn_l":"2159-8274","issn":["2159-8274","2159-8290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Discovery","raw_type":"journal-article"},{"id":"pmid:27325282","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27325282","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer discovery","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unito.it:2318/1591711","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2318/1591711","pdf_url":"https://iris.unito.it/bitstream/2318/1591711/1/Pietrantonio_CD-16-0297_PostPrint_4aperto.pdf","source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:iris.unito.it:2318/1591711","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2318/1591711","pdf_url":"https://iris.unito.it/bitstream/2318/1591711/1/Pietrantonio_CD-16-0297_PostPrint_4aperto.pdf","source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[{"id":"https://openalex.org/G5079323043","display_name":null,"funder_award_id":"17707","funder_id":"https://openalex.org/F4320323054","funder_display_name":"Associazione Italiana per la Ricerca sul Cancro"},{"id":"https://openalex.org/G8990289309","display_name":null,"funder_award_id":"IG n. 17707","funder_id":"https://openalex.org/F4320323054","funder_display_name":"Associazione Italiana per la Ricerca sul Cancro"}],"funders":[{"id":"https://openalex.org/F4320321781","display_name":"Ministero della Salute","ror":"https://ror.org/00789fa95"},{"id":"https://openalex.org/F4320322823","display_name":"Fondazione Umberto Veronesi","ror":"https://ror.org/041g7jm83"},{"id":"https://openalex.org/F4320323054","display_name":"Associazione Italiana per la Ricerca sul Cancro","ror":"https://ror.org/02g2x7380"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2471247568.pdf","grobid_xml":"https://content.openalex.org/works/W2471247568.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1922733886","https://openalex.org/W1970299210","https://openalex.org/W1980497534","https://openalex.org/W1985199765","https://openalex.org/W1985264867","https://openalex.org/W1998971866","https://openalex.org/W1999025555","https://openalex.org/W2007513598","https://openalex.org/W2014881369","https://openalex.org/W2041919461","https://openalex.org/W2055624262","https://openalex.org/W2062069596","https://openalex.org/W2119263822","https://openalex.org/W2119540121","https://openalex.org/W2127735232","https://openalex.org/W2131413118","https://openalex.org/W2133523341","https://openalex.org/W2146737519","https://openalex.org/W2160212814","https://openalex.org/W2194998434","https://openalex.org/W2207662183","https://openalex.org/W2216675461","https://openalex.org/W2272568747","https://openalex.org/W2420593137","https://openalex.org/W2461621821","https://openalex.org/W2472619494","https://openalex.org/W2531555720","https://openalex.org/W2600831328"],"related_works":["https://openalex.org/W4213113023","https://openalex.org/W2731836567","https://openalex.org/W2007513598","https://openalex.org/W2204796656","https://openalex.org/W2157049259","https://openalex.org/W4252472022","https://openalex.org/W2518274788","https://openalex.org/W4214909136","https://openalex.org/W2493930640","https://openalex.org/W2911743584"],"abstract_inverted_index":{"UNLABELLED:":[0],"A":[1],"patient":[2,86,150],"with":[3,16,22,89,105],"metastatic":[4],"BRAF-mutated":[5,53,173],"colorectal":[6,54,174],"cancer":[7,55],"initially":[8],"responded":[9],"to":[10,40,63,99,120,141,165,179],"combined":[11],"EGFR":[12,166,178],"and":[13,65,73,80,102,107,158,167],"BRAF":[14,72,103,168,184],"inhibition":[15],"panitumumab":[17,64],"plus":[18,95],"vemurafenib.":[19],"Pre-existing":[20],"cells":[21],"increased":[23],"MET":[24,44,60,74,101,153,180],"gene":[25],"copy":[26],"number":[27],"in":[28,46,82,172,187,206],"the":[29,41,47,85,90,121,127,134,139,143,191,207],"archival":[30],"tumor":[31,78],"tissue":[32],"likely":[33],"underwent":[34],"clonal":[35],"expansion":[36],"during":[37,133],"treatment,":[38],"leading":[39],"emergence":[42],"of":[43,59,110,124,129,146,163,193],"amplification":[45,154],"rebiopsy":[48],"taken":[49],"at":[50],"progression.":[51],"In":[52,208],"cells,":[56],"ectopic":[57],"expression":[58],"conferred":[61],"resistance":[62,115,164],"vemurafenib,":[66,96],"which":[67],"was":[68,87],"overcome":[69],"by":[70],"combining":[71],"inhibition.":[75],"Based":[76],"on":[77],"genotyping":[79],"functional":[81],"vitro":[83],"data,":[84],"treated":[88],"dual":[91,100],"ALK-MET":[92],"inhibitor":[93],"crizotinib":[94],"thus":[97],"switching":[98],"blockade,":[104],"rapid":[106],"marked":[108],"effectiveness":[109],"such":[111],"strategy.":[112],"Although":[113],"acquired":[114,195],"is":[116,155,204],"a":[117,160],"major":[118],"limitation":[119],"clinical":[122,188],"efficacy":[123],"anticancer":[125],"agents,":[126],"identification":[128],"molecular":[130],"targets":[131],"emerging":[132],"first":[135],"treatment":[136],"may":[137],"afford":[138],"opportunity":[140],"design":[142],"next":[144],"line":[145],"targeted":[147],"therapies,":[148],"maximizing":[149],"benefit.":[151],"SIGNIFICANCE:":[152],"here":[156],"identified-clinically":[157],"preclinically-as":[159],"new":[161],"mechanism":[162],"dual/triple":[169],"block":[170],"combinations":[171],"cancer.":[175],"Switching":[176],"from":[177],"inhibition,":[181,185],"while":[182],"maintaining":[183],"resulted":[186],"benefit":[189],"after":[190],"occurrence":[192],"MET-driven":[194],"resistance.":[196],"Cancer":[197],"Discov;":[198],"6(9);":[199],"963-71.":[200],"\u00a92016":[201],"AACR.This":[202],"article":[203],"highlighted":[205],"This":[209],"Issue":[210],"feature,":[211],"p.":[212],"932.":[213]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2471247568","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":20},{"year":2017,"cited_by_count":19},{"year":2016,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-07-22T00:00:00"}
